Aurora Cannabis Inc. (NASDAQ:ACB) finished Thursday with an addition of $0.05 to close at $0.90, an upside of 6.55 percent. An average of 8,244,779 shares of common stock have been traded in the last five days. There was a fall of -$0.0579 in the past week, and it reached a new high 3 times over the past 12 months. The last 20 days have seen an average of 12,251,275 shares traded, while the 50-day average volume stands at 12,379,902.
ACB stock has decreased by -27.82% in the last month. The company shares reached their 1-month lowest point of $0.8213 on 12/28/22. With the stock rallying to its 52-week high on 01/11/22, shares of the company touched a low of $0.82 and a high of $6.05 in 52 weeks. It has reached a new high 2 times so far this year and lost -83.32% or -$4.5078 in price. In spite of this, the price is down -85.09% from the 52-week high.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
Aurora Cannabis Inc. (ACB) stock’s beta is 2.96. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.72, the price-to-book (PB) ratio at 0.49.
The quick ratio of Aurora Cannabis Inc. for the three months ended June 29 was 2.90, and the current ratio was 3.70, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.51 and a total debt to equity ratio of 0.59 for the quarter ending June 29. Its gross profit as reported stood at $16.77 million compared to revenue of $174.88 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Aurora Cannabis Inc.’s return on assets was -111.40%.
The analyst consensus anticipated Aurora Cannabis Inc.’s latest quarter earnings to come in at -$0.15 per share, but it turned out to be $0, a 100.00% surprise. For the quarter, EBITDA amounted to -$33.61 million.
From a technical analysis perspective, let’s take a brief look at Aurora Cannabis Inc. (ACB) price momentum. RSI 9-day as of the close on 29 December was 32.31%, suggesting the stock is Neutral, with historical volatility in this time frame at 69.10%.
As of today, ACB’s price is $0.8891 -6.03% or -$0.0579 from its 5-day moving average. ACB is currently trading -28.96% lower than its 20-day SMA and -45.32% lower than its 100-day SMA. However, the stock’s current price level is -19.45% below the SMA50 and -70.22% below the SMA200.
The stochastic %K and %D were 10.46% and 8.54%, respectively, and the average true range (ATR) was 0.0768. With the 14-day stochastic at 21.94% and the average true range at 0.0853, the RSI (14) stands at 34.00%. The stock has reached -0.0578 on the 9-day MACD Oscillator while the 14-day reading was at -0.1207.
Canaccord Genuity upgraded Aurora Cannabis Inc. (NASDAQ: ACB) to a a Hold rating in its most recent analyst report. Previously, the stock was rated as a Sell. The consensus rating for Aurora Cannabis Inc. (ACB) among analysts is Hold. According to current brokerage recommendations, 0 brokerage firms advise that investors sell ACB, while 10 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 1 others rate it as a “buy”.
What is ACB’s price target for the next 12 months?
Analysts predict a range of price targets between $0.91 and $2.26, with a median target of $1.43. Taking a look at these predictions, the average price target given by analysts for Aurora Cannabis Inc. (ACB) stock is $1.44.